ArticleOncoTargets and therapy2016

Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers.

Chengyan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.